T-group (topology)
2002.5.1 EAL domain
Ligands and drugs
253
Member domains
108
with ligand contacts (≤ 4 Å)
42.7% of members
101
with DrugDomain annotations
39.9% of members
22
with a DrugBank compound
8.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.5.1 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| C2E | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) | 47 |
| CAmetal | CALCIUM ION | 39 |
| MGmetal | MAGNESIUM ION | 38 |
| HB0 | trans-4-(hydroxymethyl)cyclohexanol | 6 |
| MNmetal | MANGANESE (II) ION | 5 |
| C2I | 9-[(1R,6R,8R,9S,10R,15S,17R,18S)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-17-(6-oxidanylidene-3H-purin-9-yl)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]-3H-purin-6-one | 4 |
| CL | CHLORIDE ION | 4 |
| 4BW | 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one | 2 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 2 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 1 |
| Kmetal | POTASSIUM ION | 1 |
| NAmetal | SODIUM ION | 1 |